Drug Delivery Company Taps Genentech Executive as New President/CEO
Martin Babler has been recruited by Talima Therapeutics, a San Carlos, Calif., drug delivery company, as its new president and CEO.
Babler previously held several managerial positions with Genentech, helping manage and prepare the biotech giant’s product pipeline as senior director of commercial development, and overseeing the successful launches of Xolair and Rituxan as vice president of immunology sales and marketing.
Earlier, Babler worked at Eli Lilly and Company in various US and international strategic positions in sales, marketing, and business development. Babler is a graduate of the ETH in Zurich, Switzerland, with a degree in pharmaceutical science.
Law Firm Promotes to Partners Two Attorneys With Life Sciences Experience
The law firm Cadwalader Wickersham & Taft has promoted two of its attorneys to partners:
Dorothy Auth, a member of the firm’s intellectual property group in New York, concentrates her practice in biotechnology, pharmaceutical, and medical device patent matters in the US, as well as in Europe and Japan. Before joining Cadwalader, she was a partner with the law firm Morgan and Finnegan in New York. She earned her JD degree from St. John's School of Law, her PhD in biochemistry from Tufts Medical School, and her BA from Rutgers University.
Jonathan Kanter, a member of the firm’s antitrust group based in Washington, DC, has represented clients in mergers and acquisitions, joint ventures, and investigations by the US Department of Justice and the Federal Trade Commission. His clients have included pharmaceutical companies as well as businesses in the software, lodging, gaming, media, cable, internet, pharmaceutical, semiconductor, chemicals, and food products industries.
Before joining Cadwalader, Kanter worked for the FTC’s Bureau of Competition, and earlier served as associate editor and regular contributor to The Party Line, a publication of the American Bar Association's section of antitrust law, communications industry committee. He received his JD from Washington University, and his BA, cum laude, from the State University of New York at Albany.
The promotions expand Cadwalader’s litigation department, which numbers more than 250 lawyers, and reflect the law firm’s ongoing effort to diversify its practices to protect against economic downturns, Robert Link Jr., the firm’s chairman and managing partner, said in a press release announcing the promotions.
Molecular Diagnostics Company Names Three Top Execs to Senior Positions
Spanish-owned molecular diagnostics company Progenika Biopharma has named three executives to senior positions:
Richard Lussier has been named chief operating officer and general manager. Lussier previously established a worldwide field organization to sell, service, and support the Solexa genome analyzer, before the company was acquired last year by Illumina. Earlier, he spent 13 years at Applera, where he held a number of technical, marketing, and management roles with Applied Biosystems and Celera Genomics, including a general management position with Applera’s Japanese subsidiary.
Ignacio Martinez has been named Progenika’s CFO. Martinez joined Progenika in Spain as CFO in 2005 after many years in the international venture capital industry, investing in biotech and other high technology companies. Last year, Martinez relocated to Boston as a member of the executive team that established the company’s US subsidiary, Progenika Inc.
Martinez joined Progenika from Seed Capital, an institutional venture capital fund in Bilbao, Spain, and earlier obtained an International MBA from the Instituto de Empresa in Spain and Germany. Martinez earlier worked for Najeti Capital, an international private venture capital firm where he served as a founder-member of the team that set up the company’s Madrid offices. Martinez graduated from Deusto University, where he studied business administration.
Duncan Whitney has been named chief scientific officer. He previously served as vice president of research and development at US Genomics, developing single-molecule detection systems and a variety of research and diagnostic assays. Earlier he was vice president of technology development at Exact Sciences, where he was responsible for commercializing novel DNA-based colon cancer diagnostics tests. Whitney also held a variety of positions at PerSeptive Biosystems, now part of Applied Biosystems.
Whitney received his undergraduate degree in chemistry from Colby College and his PhD from Massachusetts Institute of Technology.
Progenika Incorporated, the US subsidiary of Progenika Biopharma founded last year, develops and markets DNA tests for predicting drug response, as well as for the diagnosis and prognosis of genetic and complex disease.
Medical Tech Developer Named Senior Director of Biomechanics and Clinical Research
Andrew Mahar has joined Alphatec Holdings, a Carlsbad, Calif., medical technology company, as senior director of biomechanics and clinical research. Alphatec Holdings is a publicly traded developer of products for the surgical treatment of spine disorders.
Mahar previously was director of the Orthopedic Biomechanics Research Center at the Rady Children's Hospital in San Diego, a position he had held since 2005. From 1998 through that year, Mahar served as a biomechanical engineer at the Rady Children's Hospital department of orthopedics.
Mahar holds a BSci degree in biomechanics from Pennsylvania State University and an MS degree in Biomechanics from the University of Massachusetts, Amherst. He is currently pursuing his PhD in orthopedic biomechanics through the Department of Orthopedics at Gothenburg University in Sweden.
Two Executives Join Scientific Equipment Reseller in Expansion to Northern California
Dawn Hocevar and Suzanne Martinez have joined BioSurplus, a San Diego provider of scientific equipment resale and asset management services to the life science industry, as part of the company’s expansion into northern California.
Hocevar has been named director of business development for the Bay Area. She previously served in various senior sales and business development positions with Fisher Scientific for over 20 years.
Martinez has been named manager of operations for the Bay Area, and will oversee the operations of the 10,000-square-foot showroom and warehouse facility that BioSurplus plans to open in the Fremont, Calif., area in March. She previously served in product marketing and account management positions for Molecular Devices Corporation and Hudson Control Group.
Veteran Northern California Brokers Bolt Colliers International for CB Richard Ellis
Two veteran northern California commercial real estate brokers have joined the San Jose office of CB Richard Ellis.
Robert Shannon has been named a senior vice president. A 24-year veteran of the Northern California real estate market, Shannon was inducted into the Association of Silicon Valley Brokers hall of fame in 1999. Throughout his career he has arranged more than 16 million square feet of lease transactions, 13 million square feet of building sale transactions, and the sale of more than 443 acres of land.
Shannon is a three-time winner of the ASVB Broker of the Year Award in the Multiple Discipline category, and has been nominated five times for the group’s All-Around Broker of the Year honor. The Society of Industrial and Office Realtors honored Shannon for the Bay Area region’s largest R&D property sale in 2003, the largest industrial sale in 2004, the largest office sale in 2005, and the largest industrial lease in 2007. He has a BSci degree in political science from the University of California, Berkeley, and holds a CCIM designation.
Joe Kelly has been named a senior associate, continuing his focus on institutional leasing and sales. Over the past three years, Kelly has completed more than 60 lease and sale transactions totaling more than 2.5 million square feet. In 2005, Kelly was named Rookie of the Year by ASVB. Kelly received a BSci degree in management from the Metropolitan State College of Denver.
Shannon and Kelly previously worked for Colliers International, and Kelly also held a development position for Catellus Development Corporation before joining Colliers